A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment.

Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, NE #254, Atlanta, GA, 30322, USA, .
Supportive Care in Cancer (Impact Factor: 2.5). 01/2013; 21(6). DOI: 10.1007/s00520-012-1688-0
Source: PubMed

ABSTRACT PURPOSE: Patients with cancer experience acute and chronic symptoms caused by their underlying disease or by the treatment. While numerous studies have examined the impact of various treatments on symptoms experienced by cancer patients, there are inconsistencies regarding the symptoms measured and reported in treatment trials. This article presents a systematic review of the research literature of the prevalence and severity of symptoms in patients undergoing cancer treatment. METHODS: A systematic search for studies of persons receiving active cancer treatment was performed with the search terms of "multiple symptoms" and "cancer" for studies involving patients over the age of 18 years and published in English during the years 2001 to 2011. Search outputs were reviewed independently by seven authors, resulting in the synthesis of 21 studies meeting criteria for generation of an Evidence Table reporting symptom prevalence and severity ratings. RESULTS: Data were extracted from 21 multi-national studies to develop a pooled sample of 4,067 cancer patients in whom the prevalence and severity of individual symptoms was reported. In total, the pooled sample across the 21 studies was comprised of 62 % female, with a mean age of 58 years (range 18 to 97 years). A majority (62 %) of these studies assessed symptoms in homogeneous samples with respect to tumor site (predominantly breast and lung cancer), while 38 % of the included studies utilized samples with mixed diagnoses and treatment regimens. Eighteen instruments and structured interviews were including those measuring single symptoms, multi-symptom inventories, and single symptom items drawn from HRQOL or health status measures. The MD Anderson Symptom Inventory was the most commonly used instrument in the studies analyzed (n = 9 studies; 43 %), while the Functional Assessment of Cancer Therapy, Hospital Anxiety and Depression Subscale, Medical Outcomes Survey Short Form-36, and Symptom Distress Scale were each employed in two studies. Forty-seven symptoms were identified across the 21 studies which were then categorized into 17 logical groupings. Symptom prevalence and severity were calculated across the entire cohort and also based upon sample sizes in which the symptoms were measured providing the ability to rank symptoms. CONCLUSIONS: Symptoms are prevalent and severe among patients with cancer. Therefore, any clinical study seeking to evaluate the impact of treatment on patients should consider including measurement of symptoms. This study demonstrates that a discrete set of symptoms is common across cancer types. This set may serve as the basis for defining a "core" set of symptoms to be recommended for elicitation across cancer clinical trials, particularly among patients with advanced disease.


Available from: Ethan Basch, Apr 04, 2014
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In Jordan, little is known about cancer-related symptoms prevalence, severity, and its impacts on patients' quality of life. Therefore, this study was conducted to estimate cancer-related symptoms prevalence, severity, and predictors of quality of life of cancer patients in Jordan. A descriptive cross-sectional survey design was used. The sample consisted of 498 Jordanian cancer patients. There were slightly more males (51.6%) and a mean age of 44.3 (SD = 15.3) years. The mean of the number of symptoms reported by patients was 11 (SD = 3.3). The most prevalent symptoms were fatigue (92.5%), feeling drowsy (87.1%), lack of appetite (86.3%), being distressed (86.1%), and pain (85.5%). Furthermore, Jordanian cancer patients had low mean total scores for quality of life at a level of 18.5 (SD = 4.9). A comprehensive palliative care program is recommended, led by a representative from the Ministry of Health, to integrate palliative care within the current health care system in Jordan. © The Author(s) 2014.
    Clinical Nursing Research 12/2014; DOI:10.1177/1054773814564212 · 0.87 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Symptom occurrence impacts primary brain tumor patients from the time of diagnosis and often heralds recurrence. In addition, the therapy can also result in symptoms that may compound tumor-associated symptoms, further impacting the patient's function and overall quality of life. There is increasing recognition that clinical studies evaluating tumor response using only measures of tumor size on imaging or survival are inadequate in brain tumor patients. Many symptoms can only be assessed from the patient, and patient reported outcome measures have been developed and have adequate reliability and validity. These measures are beginning to be incorporated into clinical trials. Guidelines on their use and meaning are needed to standardize assessment across trials and facilitate measurement of clinical benefit.
    Current Treatment Options in Oncology 08/2014; 15(4). DOI:10.1007/s11864-014-0302-8 · 3.24 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Although "fatigue" and "depression" are well-accepted clinical terms in the English language, they are ill defined in many other languages, including Portuguese. We aimed to investigate the most appropriate words to describe cancer-related fatigue (CRF) and depression in Brazilian cancer patients. Method: The interviewers read to patients two clinical vignettes describing fatigued patients and two others describing depressed patients. Participants were asked to choose from among "fatigue," "tiredness," "weakness," "depression," and "sadness" the best and worst terms to explain the vignettes. In addition, they were administered an instrument containing numeric rating scales (NRSs), addressing common symptoms, including the aforementioned terms. Pearson correlation analysis and accuracy diagnostic tests were conducted using the Hospital Anxiety and Depression Scale (HADS) and the Functional Assessment of Cancer Treatment-Fatigue (FACIT-F) as references. Results: Among the 80 participants, 40% reported that the best term to explain the concept of CRF was "tiredness," and 59% chose "sadness" as the best descriptor of depression. Regarding diagnostic accuracy, the areas under the curve (AUCs) for "fatigue," "weakness," and "tiredness" were 0.71, 0.81, and 0.76, respectively; the AUCs for "depression" and "sadness" ranged from 0.81 to 0.91 and 0.73 to 0.83, respectively. Negative correlations were found among FACIT-F fatigue subscale scores and NRS scores for "fatigue" (r = -0.58), "tiredness" (r = -0.67), and "weakness" (r = -0.62). Regarding depression, there were positive correlations between HADS-D scores and both NRS for "depression" (r = 0.61) and "sadness" (r = 0.54). Significance of results: "Tiredness" was considered the best descriptor of CRF. Taking into consideration the clinical correlation with depression scores, the term "depression" was accepted as the best term to explain the concept of depression.
    Palliative and Supportive Care 08/2014; DOI:10.1017/S1478951514000868 · 0.98 Impact Factor